Leprosy: A Review of Epidemiology, Clinical Diagnosis, and Management

Table 3

Summarized the treatment regimen recommended from World Health Organization.

Diagnosis	Population	Medication	Dose	Duration
Paucibacillary leprosy
	Adults
		Rifampicin	600 mg/month	6 months
		Clofazimine	300 mg/month + 50 mg/day	6 months
		Dapsone	100 mg/day	6 months
	Children (10–14 years)
		Rifampicin	450 mg/month	6 months
		Clofazimine	150 mg/month + 50 mg/day	6 months
		Dapsone	50 mg/day	6 months
	Children (<10 years old or <40 kg)
		Rifampicin	10 mg/kg/month	6 months
		Clofazimine	6 mg/kg/month + 1 mg/kg/day	6 months
		Dapsone	2 mg/kg/daily	6 months
Multibacillary leprosy
	Adult
		Rifampicin	600 mg/month	12 months
		Clofazimine	300 mg/month + 50 mg/day	12 months
		Dapsone	100 mg/day	12 months
	Children (10–14 years)
		Rifampicin	450 mg/month	12 months
		Clofazimine	150 mg/month + 50 mg/day	12 months
		Dapsone	50 mg/day	12 months
	Children (<10 years old or <40 kg
		Rifampicin	10 mg/kg/month	12 months
		Clofazimine	6 mg/kg/month + 1 mg/kg/day	12 months
		Dapsone	2 mg/kg/daily	12 months